ICOM
BIO icon

Investment Counselors of Maryland’s Bio-Rad Laboratories Class A BIO Stock Holding History

Investment Counselors of Maryland’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-914
Closed -$304K – 195
2019
Q3 		$304K Hold
914
– – 0.01% 140
2019
Q2 		$286K Hold
914
– – 0.01% 146
2019
Q1 		$279K Hold
914
– – 0.01% 145
2018
Q4 		$212K Sell
914
-269
-23% -$72.2K 0.01% 155
2018
Q3 		$370K Buy
1,183
+51
+5% +$15.8K 0.02% 153
2018
Q2 		$327K Sell
1,132
-83
-7% -$22.9K 0.02% 150
2018
Q1 		$304K Sell
1,215
-66,119
-98% -$16.8M 0.02% 159
2017
Q4 		$16.1M Buy
67,334
+199
+0.3% +$48.2K 0.8% 77
2017
Q3 		$14.9M Sell
67,135
-12,055
-15% -$2.71M 0.76% 80
2017
Q2 		$17.9M Sell
79,190
-50
-0.1% -$10.9K 0.93% 52
2017
Q1 		$15.8M Sell
79,240
-500
-0.6% -$96.3K 0.83% 67
2016
Q4 		$14.5M Hold
79,740
– – 0.77% 77
2016
Q3 		$13.1M Sell
79,740
-12,030
-13% -$1.83M 0.78% 72
2016
Q2 		$13.1M Hold
91,770
– – 0.72% 80
2016
Q1 		$12.5M Hold
91,770
– – 0.72% 81
2015
Q4 		$12.7M Hold
91,770
– – 0.73% 75
2015
Q3 		$12.3M Sell
91,770
-39,450
-30% -$5.68M 0.72% 77
2015
Q2 		$19.8M Hold
131,220
– – 0.92% 39
2015
Q1 		$17.7M Sell
131,220
-39,600
-23% -$4.91M 0.84% 57
2014
Q4 		$20.6M Sell
170,820
-3,225
-2% -$371K 1% 36
2014
Q3 		$19.7M Sell
174,045
-4,399
-2% -$521K 0.98% 39
2014
Q2 		$21.4M Sell
178,444
-9,711
-5% -$1.19M 0.92% 51
2014
Q1 		$24.1M Sell
188,155
-28,695
-13% -$3.68M 1.02% 26
2013
Q4 		$26.8M Sell
216,850
-5,700
-3% -$695K 1.09% 18
2013
Q3 		$26.2M Sell
222,550
-22,900
-9% -$2.7M 1.11% 19
2013
Q2 		$27.5M Buy
+245,450
New +$28.8M 1.22% 7

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Investment Counselors of Maryland's BIO Position: Q4 2019 in Review

Investment Counselors of Maryland sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2019, closing a stake of 914 shares — an estimated $304K sold.

Investment Counselors of Maryland first reported a position in BIO in Q2 2013 and held it in 26 quarters. The position peaked at $27.5M in Q2 2013. 387 funds tracked by Wall St. Rank hold BIO as of Q4 2019.

  • Investment Counselors of Maryland reported no remaining Bio-Rad Laboratories Class A position as of Q4 2019 after selling out during the quarter.
  • Investment Counselors of Maryland sold 914 Bio-Rad Laboratories Class A shares in Q4 2019, an estimated $304K.
  • Investment Counselors of Maryland first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 26 quarters.
  • Investment Counselors of Maryland's Bio-Rad Laboratories Class A position peaked at $27.5M in Q2 2013.
  • 387 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2019.

Based on Investment Counselors of Maryland's 13F filing for Q4 2019, filed 11 Feb 2020.